Aytu BioScience (NASDAQ:AYTU) rises ~8% in premarket, after the company announces delivery of Healight investigational devices, for use in upcoming COVID-19 clinical studies. The device is designed by Sterling Medical Devices.
The pilot scale devices employ proprietary methods of administering intermittent ultraviolet A light via a respiratory tract device.
Pre-clinical findings indicate the technology’s significant impact on reducing a range of viral and bacterial loads, including the coronavirus HCoV-229E.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.